Evolent Health Inc Class A EVH 深 沪
等待开盘 05-19 09:30:00 美东时间
3.90
-0.060
-1.52%
华盛通- 最 高4.14
- 今 开3.98
- 成交量 196.86万股
- 最 低 3.88
- 昨 收 3.96
- 总市值 4.39亿
- 52周最高 12.065
- 市盈率 静 --
- 换手率 1.75%
- 52周最低 2.095
- 委 比 50.00%
- 总股本 1.12亿
- 历史最高 39.779
- 量 比 0.62
- 振 幅 6.57%
- 历史最低 2.095
- 每 手 1
- 风险率 2.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
Citigroup Maintains Buy on Evolent Health, Raises Price Target to $5.5
Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $4 to $5.5.
05-16 02:28
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
Evolent Health shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results and reaffirmed its FY2026 sales guidance.
Evolent Health shares are trading higher after the company reported better-than...
05-08 00:02
财报速睇 | Evolent Health Inc Class A 2026财年Q1营收4.96亿美元，同比增长2.5%；归母净利润亏损0.27亿美元，同比亏损缩窄63.1%
华盛资讯5月7日讯，Evolent Health Inc Class A公布2026财年Q1业绩，公司Q1营收4.96亿美元，同比增长2.5%，归母净利润亏损0.27亿美元，同比亏损缩窄63.1%。
05-07 20:28
XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acquire XOMA for $39.00/share. Other big gainers: MANE, ORKA, OGN, XE, PLBL, SLS, ANAB, EVH, IHRT, RPAY, JBIO, BEAM.
04-27 22:20
Evolent Health appoints Archie Mayani as chief product officer
Evolent Health appoints Archie Mayani as chief product officer Evolent appointed Archie Mayani as chief product officer. Mayani previously served as chief product officer at GHX and Change Healthcare. Her earlier roles included leadership positions at Optum and UnitedHealth Group, and global head of
03-19 20:45
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
Evolent Health Charts Growth Amid 2026 Margin Squeeze
Evolent Health Inc. (($EVH)) has held its Q4 earnings call. Read on for the mai...
03-01 08:11
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
